| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $13.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $64.88 | $1,621,894.25 | -1.6% | -22.7% | -16.7% | |
| Apr 25, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $50.67 | $1,266,637.58 | -3.1% | +12.3% | +12.6% | |
| Mar 29, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $44.46 | $1,111,503.52 | -3.1% | +23.6% | +50.9% | |
| Feb 27, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $48.25 | $1,206,243.36 | -2.1% | +31.5% | +81.3% | |
| Jan 27, 2023 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $51.47 | $1,286,797.52 | -3.2% | -7.0% | +15.6% | |
| Dec 28, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $40.93 | $1,023,290.03 | -3.3% | +11.9% | +64.1% | |
| Nov 28, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $54.03 | $1,350,826.80 | -2.8% | -7.8% | +32.5% | |
| Oct 26, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 32,312 | $54.96 | $1,775,711.31 | -2.6% | -5.9% | -29.1% | |
| Sep 28, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $64.61 | $1,615,160.24 | -4.1% | -38.7% | -31.7% | |
| Aug 29, 2022 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 25,000 | $66.84 | $1,671,084.48 | -2.7% | -18.9% | -23.1% |